Sox2 Level Is a Determinant of Cellular Reprogramming Potential

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Han, Dong Wook ^a,b   Tapia, Natalia ^c   Araúzo Bravo, Marcos J ^c   Lim, Kyung Tae ^a   Kim, Kee Pyo ^c   Ko, Kinarm ^a,b   Lee, Hoon Taek ^a   Schöler, Hans R ^c,d  

^a Konkuk University School of Medicine   (South Korea)

^b Konkuk University   (South Korea)

^c MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; SOX2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CYTOLOGY; ECTODERM; EMBRYONIC STEM CELL; FEMALE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; CELLULAR REPROGRAMMING; MICE; SOXB1 TRANSCRIPTION FACTORS;

EID: 84879145110     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067594     Document Type: Article

References (24)

1. Brons IG, Smithers LE, Trotter MW, Rugg-Gunn P, Sun B, et al. (2007) Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448: 191-195. doi:10.1038/nature05950. PubMed: 17597762.
2. Nichols J, Smith A, (2009) Naive and primed pluripotent states. Cell Stem Cell 4: 487-492. doi:10.1016/j.stem.2009.05.015. PubMed: 19497275.
3. Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, et al. (2007) New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448: 196-199. doi:10.1038/nature05972. PubMed: 17597760.
4. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, et al. (2003) Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17: 126-140. doi:10.1101/gad.224503. PubMed: 12514105.
5. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, et al. (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956. doi:10.1016/j.cell.2005.08.020. PubMed: 16153702.
6. Chambers I, Silva J, Colby D, Nichols J, Nijmeijer B, et al. (2007) Nanog safeguards pluripotency and mediates germline development. Nature 450: 1230-1234. doi:10.1038/nature06403. PubMed: 18097409.
7. Han DW, Greber B, Wu G, Tapia N, Araúzo-Bravo MJ, et al. (2011) Direct reprogramming of fibroblasts into epiblast stem cells. Nat Cell Biol 13: 66-71. doi:10.1038/ncb2136. PubMed: 21131959.
8. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676. doi:10.1016/j.cell.2006.07.024. PubMed: 16904174.
9. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920. doi:10.1126/science.1151526. PubMed: 18029452.
10. McBurney MW, (1993) P19 embryonal carcinoma cells. Int J Dev Biol 37: 135-140. PubMed: 8507558.
11. Han DW, Tapia N, Joo JY, Greber B, Araúzo-Bravo MJ, et al. (2010) Epiblast stem cell subpopulations represent mouse embryos of distinct pregastrulation stages. Cell 143: 617-627. doi:10.1016/j.cell.2010.10.015. PubMed: 21056461.
12. Silva J, Nichols J, Theunissen TW, Guo G, van Oosten AL, et al. (2009) Nanog is the gateway to the pluripotent ground state. Cell 138: 722-737. doi:10.1016/j.cell.2009.07.039. PubMed: 19703398.
13. Yeom YI, Fuhrmann G, Ovitt CE, Brehm A, Ohbo K, et al. (1996) Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122: 881-894. PubMed: 8631266.
14. Han DW, Do JT, Gentile L, Stehling M, Lee HT, et al. (2008) Pluripotential reprogramming of the somatic genome in hybrid cells occurs with the first cell cycle. Stem Cells 26: 445-454. doi:10.1634/stemcells.2007-0553. PubMed: 18065396.
15. Silva J, Chambers I, Pollard S, Smith A, (2006) Nanog promotes transfer of pluripotency after cell fusion. Nature 441: 997-1001. doi:10.1038/nature04914. PubMed: 16791199.
16. Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, et al. (2007) A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25: 681-686. doi:10.1038/nbt1310. PubMed: 17529971.
17. McBurney MW, Reuhl KR, Ally AI, Nasipuri S, Bell JC, et al. (1988) Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture. J Neurosci 8: 1063-1073. PubMed: 2894413.
18. Do JT, Han DW, Gentile L, Sobek-Klocke I, Wutz A, et al. (2009) Reprogramming of Xist against the pluripotent state in fusion hybrids. J Cell Sci 122: 4122-4129. doi:10.1242/jcs.056119. PubMed: 19843582.
19. Do JT, Han DW, Gentile L, Sobek-Klocke I, Stehling M, et al. (2008) Enhanced reprogramming of Xist by induced upregulation of Tsix and Dnmt3a. Stem Cells 26: 2821-2831. doi:10.1634/stemcells.2008-0482. PubMed: 18757295.
20. Kopp JL, Ormsbee BD, Desler M, Rizzino A, (2008) Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 26: 903-911. doi:10.1634/stemcells.2007-0951. PubMed: 18238855.
21. Zhao S, Nichols J, Smith AG, Li M, (2004) SoxB transcription factors specify neuroectodermal lineage choice in ES cells. Mol Cell Neurosci 27: 332-342. doi:10.1016/j.mcn.2004.08.002. PubMed: 15519247.
22. Navarro P, Chambers I, Karwacki-Neisius V, Chureau C, Morey C, et al. (2008) Molecular coupling of Xist regulation and pluripotency. Science 321: 1693-1695. doi:10.1126/science.1160952. PubMed: 18802003.
23. Han DW, Do JT, Araúzo-Bravo MJ, Lee SH, Meissner A, et al. (2009) Epigenetic hierarchy governing Nestin expression. Stem Cells 27: 1088-1097. doi:10.1002/stem.43. PubMed: 19415779.
24. Wutz A, Jaenisch R, (2000) A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation. Mol Cell 5: 695-705. doi:10.1016/S1097-2765(00)80248-8. PubMed: 10882105.